Tesamorelin is a stabilized analog of human growth-hormone-releasing hormone. It is built on the full GHRH(1-44) sequence with an N-terminal modification that resists enzymatic degradation, making it a robust tool compound for growth-hormone-axis research.
Design and class
As a GHRH analog it acts upstream at the GHRH receptor, sharing a mechanistic class with sermorelin and CJC-1295 (no DAC) while offering greater metabolic stability. Its full-length backbone and acyl cap are detailed in the structure and synthesis article.
Why it is studied
Tesamorelin has been a subject of metabolic research, particularly around adipose-tissue endpoints in preclinical and cell models, where GHRH-receptor tools serve as useful upstream probes. Selective GHS-R agonists such as ipamorelin provide a complementary comparator, letting researchers separate GHRH-receptor and ghrelin-receptor inputs.
Position on the stability spectrum
Among GHRH analogs, tesamorelin occupies a distinct point defined by its full-length sequence and N-terminal cap, contrasting with truncated fragments and albumin-binding designs. This makes it a valuable reference when characterizing how stabilization strategy shapes duration.
Research context
As with all research peptides, reproducibility depends on documented identity and purity — see third-party testing explained.
How it functions as a comparator
Tesamorelin is useful not only as an individual test article but also as a reference against shorter or differently stabilized GHRH analogs. Comparisons can ask whether an observed difference follows from the full-length backbone, the N-terminal cap, albumin association, or protease-resistant residue substitutions. Keeping those variables explicit prevents all GHRH-family peptides from being treated as interchangeable and supports more precise interpretation of receptor and time-course experiments.
Product page: Tesamorelin research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.